RxSight (RXST) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2026)
RxSight (RXST) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 7.96% |
| 10 | RxSight | 250.19 Mn | -154.06 Mn | - | 10.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.05% |
| Mar 31, 2026 | 10.51% |
| Dec 31, 2025 | 8.80% |
| Sep 30, 2025 | 7.24% |
| Jun 30, 2025 | 6.15% |
| Mar 31, 2025 | 4.78% |
| Dec 31, 2024 | 3.43% |
| Sep 30, 2024 | 0.69% |
| Jun 30, 2024 | -0.64% |
| Dec 31, 2023 | -6.56% |